| Value | ₹5.90 Cr |
|---|---|
| Execution period | 3 to 6 months |
NSE filing, NSE: GRETEX. Summary written from the filing by ALFA Finder's alert engine.
More from Gretex Industries Ltd
All →Gretex Industries Annual General Meeting
Gretex Industries Limited announced the voting results of its Postal Ballot. Shareholders approved all four resolutions, including the sale of its investment in a subsidiary.
Gretex Industries Capital Structure Change
Gretex Industries allotted 3,09,660 equity shares to its promoter group upon conversion of warrants at Rs. 236 per share. This is the third tranche.
- Value
- ₹5.48 Cr
Gretex Industries Business Update
Gretex Industries Limited has been appointed as an authorised dealer for pro audio products by Sony India Private Limited in West Bengal.
- From
- Sony India Private Limited
Gretex Industries Annual General Meeting
Gretex Industries Limited issued a postal ballot notice seeking shareholder approval for the sale of its interests in three subsidiary entities to related parties.
Gretex Industries Acquisition
Gretex Industries Limited entered a Share Purchase Agreement to acquire a 98% stake in Arpan Tie Up Pvt Ltd, making it a subsidiary.
Gretex Industries Board Meeting Outcome
Gretex Industries approved the sale of its entire stake in subsidiaries Gretex RS Properties LLP, Gretex Aran Properties LLP, and Sunview Nirman Private Limited.
- Value
- ₹26.90 Cr
- Execution
- within one year
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.